These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 9308128)

  • 21. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
    Arroyo V; Terra C; Ginès P
    J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of hepatorenal syndrome].
    Guevara M
    Gastroenterol Hepatol; 2003 Apr; 26(4):270-4. PubMed ID: 12681123
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatorenal syndrome: pathophysiology and management.
    Wadei HM; Mai ML; Ahsan N; Gonwa TA
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1066-79. PubMed ID: 17699328
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of hepatorenal syndrome].
    Walter E
    Praxis (Bern 1994); 1997 Jan; 86(4):102-3. PubMed ID: 9064719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Update on hepatorenal syndrome].
    Blaise P; Moonen M; Rorive G
    Nephrologie; 2002; 23(1):11-7. PubMed ID: 11887572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The therapy of the hepatorenal syndrome in liver cirrhosis].
    Biecker E; Brensing KA; Perz J; Woitas R; Sauerbruch T
    Dtsch Med Wochenschr; 1999 Sep; 124(36):1039-42. PubMed ID: 10506842
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of hepatorenal syndrome.
    Kiser TH; Maclaren R; Fish DN
    Pharmacotherapy; 2009 Oct; 29(10):1196-211. PubMed ID: 19792993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatorenal syndrome: definition, pathophysiology, clinical features and management.
    Bataller R; Sort P; Ginès P; Arroyo V
    Kidney Int Suppl; 1998 May; 66():S47-53. PubMed ID: 9573573
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatorenal syndrome in patients with liver cirrhosis].
    Zaza S; Bonny O; Liaudet L
    Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatorenal syndrome: a critical update.
    Wadei HM
    Semin Respir Crit Care Med; 2012 Feb; 33(1):55-69. PubMed ID: 22447261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P; Laffi G; La Villa G; Raggi VC
    Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatorenal syndrome].
    Lautrette A; Liotier J; Deteix P; Souweine B
    Nephrol Ther; 2009 Apr; 5(2):150-6. PubMed ID: 18514053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A; Terra C; Guevara M; Ginès P
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract]   [Full Text] [Related]  

  • 35. TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?
    Gülberg V; Gerbes AL
    Z Gastroenterol; 2002 Sep; 40(9):823-6. PubMed ID: 12215953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F; Raina N; Richardson R
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatorenal syndrome: new perspectives in pathophysiology and management.
    Kes P
    Acta Med Croatica; 2000; 54(4-5):165-73. PubMed ID: 11379481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of hepatorenal syndrome.
    McCormick PA; Donnelly C
    Pharmacol Ther; 2008 Jul; 119(1):1-6. PubMed ID: 18539334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome.
    Suzuki H; Stanley AJ
    QJM; 2001 Jun; 94(6):293-300. PubMed ID: 11391027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology, clinical features and management of hepatorenal syndrome.
    Garzia P; Ferri GM; Ilardi M; Messina FR; Amoroso A
    Eur Rev Med Pharmacol Sci; 1998; 2(5-6):181-4. PubMed ID: 10710816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.